Drug Trial Radar · NCT07030868
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Jun 19, 2025
Primary completion
Jul 29, 2025
Study completion Jul 29, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jun 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.
Conditions
- Obesity
- Overweight
- Type 2 Diabetes
Interventions
LY3549492Drug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body WeightTime frame: Baseline, Week 32
Locations
42 sites in 2 countries. Site status is shown where the registry gives one.
HOPE Research Institute
Phoenix, Arizona
Headlands Research - Scottsdale
Scottsdale, Arizona
NorCal Medical Research, Inc
Greenbrae, California
Velocity Clinical Research, Huntington Park
Huntington Park, California
Peninsula Research Associates
Rolling Hills Estates, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Stamford Therapeutics Consortium
Stamford, Connecticut
Northeast Research Institute (NERI)
Fleming Island, Florida
Indago Research & Health Center, Inc
Hialeah, Florida
New Horizon Research Center
Miami, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
Charter Research - Winter Park
Orlando, Florida
Charter Research - Lady Lake
The Villages, Florida
Medical Research Partners
Ammon, Idaho
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas
Knownwell
Needham, Massachusetts
Lucida Clinical Trials
New Bedford, Massachusetts
Headlands Research - Detroit
Southfield, Michigan
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan
Clinvest Headlands Llc
Springfield, Missouri
Las Vegas Medical Research
Las Vegas, Nevada
Velocity Clinical Research, Syracuse
East Syracuse, New York
Rochester Clinical Research, LLC
Rochester, New York
Monroe Biomedical Research
Monroe, North Carolina
Lucas Research, Inc
Morehead City, North Carolina
Lucas Research, Inc.
New Bern, North Carolina
Quality Medical Research
Nashville, Tennessee
IMA Clinical Research Austin
Austin, Texas
Velocity Clinical Research, Dallas
Dallas, Texas
FutureSearch Trials of Dallas
Dallas, Texas
PlanIt Research, PLLC
Houston, Texas
Tekton Research - Fredericksburg Road
San Antonio, Texas
Endeavor Clinical Trials
San Antonio, Texas
Texas Valley Clinical Research
Weslaco, Texas
Spectrum Medical, Inc.
Danville, Virginia
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina
Centro Médico Viamonte
Buenos Aires, Buenos Aires F.D., Argentina
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.